NO995831L - Klar injiserbar formulering av en anestetisk forbindelse - Google Patents

Klar injiserbar formulering av en anestetisk forbindelse

Info

Publication number
NO995831L
NO995831L NO995831A NO995831A NO995831L NO 995831 L NO995831 L NO 995831L NO 995831 A NO995831 A NO 995831A NO 995831 A NO995831 A NO 995831A NO 995831 L NO995831 L NO 995831L
Authority
NO
Norway
Prior art keywords
injectable formulation
anesthetic compound
clear
clear injectable
anesthetic
Prior art date
Application number
NO995831A
Other languages
English (en)
Other versions
NO995831D0 (no
Inventor
Vincenzo Tommaso
Original Assignee
Westy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westy Ag filed Critical Westy Ag
Publication of NO995831D0 publication Critical patent/NO995831D0/no
Publication of NO995831L publication Critical patent/NO995831L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995831A 1997-05-26 1999-11-26 Klar injiserbar formulering av en anestetisk forbindelse NO995831L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH01224/97A CH692322A5 (it) 1997-05-26 1997-05-26 Formulazione iniettabile limpida di Propofol.
PCT/EP1998/003004 WO1998053805A1 (en) 1997-05-26 1998-05-14 Clear, injectable formulation of an anesthetic compound

Publications (2)

Publication Number Publication Date
NO995831D0 NO995831D0 (no) 1999-11-26
NO995831L true NO995831L (no) 2000-01-26

Family

ID=4205400

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995831A NO995831L (no) 1997-05-26 1999-11-26 Klar injiserbar formulering av en anestetisk forbindelse

Country Status (23)

Country Link
US (1) US6326406B1 (no)
EP (1) EP0991405B1 (no)
JP (1) JP2001527577A (no)
KR (1) KR20010013011A (no)
CN (1) CN1268051A (no)
AR (1) AR012853A1 (no)
AT (1) ATE230984T1 (no)
AU (1) AU735020B2 (no)
BR (1) BR9809492A (no)
CA (1) CA2291261A1 (no)
CH (1) CH692322A5 (no)
DE (1) DE69810771D1 (no)
DZ (1) DZ2503A1 (no)
HU (1) HUP0002117A3 (no)
IN (1) IN187550B (no)
MY (1) MY132911A (no)
NO (1) NO995831L (no)
PA (1) PA8451701A1 (no)
PE (1) PE75299A1 (no)
PL (1) PL337026A1 (no)
TR (1) TR200000116T2 (no)
WO (1) WO1998053805A1 (no)
ZA (1) ZA984314B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
DE69922252T2 (de) * 1999-01-28 2005-12-01 Patel, Dinesh Shantilal Parenterale lösungen enthaltend propofol (2,6-diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol als lösungsmittel
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6635456B2 (en) * 2001-02-09 2003-10-21 Fidia Farmaceutici S.P.A. Procedure for the preparation of pure phosphatides with phospholipase D
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
KR100482269B1 (ko) * 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
SI1585548T1 (sl) 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
JP2005154305A (ja) * 2003-11-21 2005-06-16 Showa Yakuhin Kako Kk ヒアルロン酸含有組成物の製造方法
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
CN101291658B (zh) 2005-08-31 2014-04-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
RU2433818C2 (ru) 2005-08-31 2011-11-20 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Композиции, включающие слаборастворимые в воде фармацевтические вещества и противомикробные вещества
JP2012509339A (ja) * 2008-11-20 2012-04-19 テイコク ファーマ ユーエスエー インコーポレーテッド ピラゾロン誘導体製剤
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
WO2019173526A1 (en) * 2018-03-07 2019-09-12 Andrew Xian Chen Aqueous formulations for insoluble drugs
JP7063217B2 (ja) * 2018-09-27 2022-05-09 住友電気工業株式会社 光ファイバの製造方法
JP7135670B2 (ja) * 2018-09-27 2022-09-13 住友電気工業株式会社 光ファイバ及び紫外線硬化型樹脂組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089510B (de) 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
GB1472793A (en) 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
DE3221579A1 (de) 1982-06-08 1983-12-22 Eckert, Theodor, Prof. Dr., 4400 Münster Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen
CA1319886C (en) 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
AU6708096A (en) * 1995-09-18 1997-04-09 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
CA2291261A1 (en) 1998-12-03
PE75299A1 (es) 1999-08-26
TR200000116T2 (tr) 2000-05-22
ATE230984T1 (de) 2003-02-15
PL337026A1 (en) 2000-07-31
ZA984314B (en) 1998-12-08
BR9809492A (pt) 2000-06-20
DE69810771D1 (de) 2003-02-20
AU735020B2 (en) 2001-06-28
IN187550B (no) 2002-05-18
JP2001527577A (ja) 2001-12-25
PA8451701A1 (es) 2000-05-24
WO1998053805A1 (en) 1998-12-03
AU8209798A (en) 1998-12-30
CN1268051A (zh) 2000-09-27
AR012853A1 (es) 2000-11-22
NO995831D0 (no) 1999-11-26
CH692322A5 (it) 2002-05-15
US6326406B1 (en) 2001-12-04
EP0991405B1 (en) 2003-01-15
EP0991405A1 (en) 2000-04-12
HUP0002117A2 (hu) 2000-12-28
HUP0002117A3 (en) 2001-04-28
DZ2503A1 (fr) 2005-01-25
MY132911A (en) 2007-10-31
KR20010013011A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
NO995831L (no) Klar injiserbar formulering av en anestetisk forbindelse
NO952357D0 (no) Formulering av insulinanaloger
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
FI972292A (fi) Diabeteksen hallinta
ATE263147T1 (de) Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
ID24372A (id) SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs
DE69815099T2 (de) Kosmetische zusammensetzungen
ID24654A (id) Formulasi farmasi omeprazola
PT925083E (pt) Seringas
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
BR1100329A (pt) Composto e formulação farmacêutica
ATE263541T1 (de) Kosmetische formulierung
PT868183E (pt) Formulacoes injectaveis de quinolona
BR9707501A (pt) Composto composição farmacêutica e uso do composto
IT1304793B1 (it) Miscela di stabilizzanti
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
PT1028718E (pt) Formulacao de libertacao prolongada
DE69812588D1 (de) Medizinischer injektor
BR9707808A (pt) Composto composição farmacêutica e uso do composto
IT1304794B1 (it) Miscela di stabilizzanti
NO20003105D0 (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
ID24677A (id) Kombinasi senyawa aktif fungisidal
ID16838A (id) Komposisi dekafluoropentana

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application